Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: J Pathol. 2010 Sep;222(1):110–116. doi: 10.1002/path.2739

Figure 2.

Figure 2

A) Graphical display of absolute SCOUT frequency in controls, asymptomatic women with BRCA+ and women with serous carcinoma; B) normalized to allow for differences in sampling by showing SCOUT frequency as a function of tissue section examined. C) Multiple BCL2 positive SCOUTs in a section of normal tube (arrows) from a subject with serous carcinoma (See Table 2, samples 04).